Cash Flow Statement

Rentokil Initial (RTO) Common Equity (2021 - 2025)

Rentokil Initial (RTO) has disclosed Common Equity for 5 consecutive years, with $5.5 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 1.22% to $5.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 billion through Dec 2025, up 1.22% year-over-year, with the annual reading at $5.5 billion for FY2025, 3.76% up from the prior year.
  • Common Equity for Q4 2025 was $5.5 billion at Rentokil Initial, up from $5.4 billion in the prior quarter.
  • The five-year high for Common Equity was $5.5 billion in Q4 2025, with the low at $1.7 billion in Q4 2021.
  • Average Common Equity over 5 years is $4.5 billion, with a median of $5.1 billion recorded in 2023.
  • The sharpest move saw Common Equity surged 182.1% in 2022, then rose 1.22% in 2025.
  • Over 5 years, Common Equity stood at $1.7 billion in 2021, then soared by 182.1% to $4.8 billion in 2022, then increased by 5.56% to $5.1 billion in 2023, then increased by 6.98% to $5.4 billion in 2024, then increased by 1.22% to $5.5 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $5.5 billion, $5.4 billion, and $5.1 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.